Clinical Certificate

Drug Treatments in Affective Disorders

Date: Thursday 10th September 2020 – Friday 11th September 2020
Venue: The International Centre For Life (Conferences), Times Square, Newcastle Upon Tyne, NE1 4EP
Accommodation: Jury's Inn, Scotswood Road, Newcastle , NE1 4AD
(accommodation is bookable separately when you complete the online booking form)

Programme

Programme to be confirmed

Last edited 24th October 2019

Learning Objectives

  • Natural history and pathophysiology of affective disorders
    • To understand the Natural History of Mood Disorders
    • To be aware of the main theories of the pathophysiology of mood disorders and the
      relationship of these to drugs
  • Pharmacokinetics and mechanism of action of antidepressants
    • To understand the basic pharmacokinetics of antidepressants
    • To understand the relevance of differing pharmacokinetic properties of antidepressants to their clinical usage
    • To understand the presumed mechanism of action of various classes of antidepressant drugs
  • Antidepressants in clinical practice
    • To recognise various stages in the management of patients with antidepressants
    • To understand how various classes of antidepressants may be used clinically
    • To know the details of published guidelines regarding the choice and clinical usage of antidepressants
  • Management of treatment resistant depression
    • To understand the epidemiology, clinical features and associations of this disorder.
    • To be able to construct a rational management plan.
    • To explore the evidence base in this topic and make rational pharmacological treatment plans.
    • To be able to consider what additional investigations or treatments are required.
  • Lithium
    • To understand how Lithium may be used clinically
    • To know the details of published guidelines regarding the choice and clinical usage of Lithium
    • To appreciate the neurobiological underpinnings of Lithium’s actions
  • Other treatments for bipolar disorder
    • To be able to construct a rational management plan.
    • To explore the evidence base in this topic and make rational pharmacological treatment plans.
    • To be able to consider what additional investigations or treatments are required.

This module is eligible for 10 CPD hours which are subject to peer group review.

For further details contact , BAP Executive Officer

Feedback from 2019 Module

"Thank you for organising a very interesting and relevant course, there were plenty of opportunities to ask questions"

"The organisation by BAP was superb!"

"Great speakers and facilities, really useful and inspiring"

"Useful and has inspired me to study more"